Periimplantitis and soft-tissue defects of dental implants – A pilot study on the fixing of the suprastructure as a possible factor affecting aetiology

Not Applicable

• Conditions: Retention of implant-supported single crowns; K08.1; Loss of teeth due to accident, extraction or local periodontal disease

• Registration Number: DRKS00004158
• Lead Sponsor: niversitätsklinikum HeidelbergMund-Zahn-Kieferklinik, MZK IIPoliklinik für Zahnärztliche Prothetik

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2012-07-27
• Study Completion: 2016-12-31
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Inclusion criteria consist of signing the informed consent, being in the age of 18-100 and legally competent. Only patients with a bonelevel-implant, that is osseointegrated and has no clinical signs of inflammation will be included. Patient must be informed in detail about the treatment procedure, the randomization and the costs.

Exclusion Criteria

Exclusion criteria are: vulnerable patients, pregnancy or brestfed, patients with tissue level implants or bonelevel implants that have clinical signs of mucositis or periimplantitis, missing informed consent, refusing the randomization and patients with bisphosphonates or radiation therapy in the head or neck area.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome is to examine the undetected excess cement on standard and individual abutments after 2 weeks (explorative examination).

Secondary Outcome Measures

Name	Time	Method
Secondary outcomes are the examination of the periimplant soft tissue for volumetric changes or signs of inflammation, and cases of loss of retention will also be documented.